Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

NCT04666272

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Changsha, Hunan, China
View Trial Details
Active, Not Recruiting

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

NCT05488483

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Memorial Sloan Kettering Bergen (Consent only ) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Commack, New York, United States
  • Memorial Sloan - Kettering Cancer Center New York, United States
  • Helmholtz Institute (Data Analysis Only) Munich, Germany
View Trial Details
Active, Not Recruiting

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

NCT03794349

Conditions
High Risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Miller Children's and Women's Hospital Long Beach Long Beach, California, United States
View all 145 locations
View Trial Details
Active, Not Recruiting

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

NCT05987332

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
View all 68 locations
View Trial Details

Related conditions